| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |